AI could predict when prostate cancer becomes resistant to treatment
NCT ID NCT07376057
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an artificial intelligence (AI) model that uses images from prostate biopsies to predict when prostate cancer will become resistant to hormone therapy. Researchers will enroll 150 patients with intermediate- to high-risk prostate cancer who are starting hormone therapy. The AI analyzes digitized biopsy slides and predicts whether resistance will occur within 12 months, between 12 and 24 months, or after 24 months. The goal is to see how well the AI's predictions match what actually happens.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Artificial intelligence (AI) model analyzing biopsy images
- What this could lead to
- If successful, this AI tool could help doctors personalize treatment plans by predicting how long hormone therapy will work for each patient.
- What could go wrong
- This is a small, early-stage validation study. The AI model may not be accurate enough for real-world use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill slow advanced prostate cancer?
- Radiation plus hormone therapy may slow resistant prostate cancer
- Real-World data may reveal Pluvicto's true impact on advanced prostate cancer survival
- Mapping the next steps: how men with advanced prostate cancer are treated after standard therapies fail
- Massive data dive aims to uncover best prostate cancer treatments in real life
- New pill aims to shrink Hard-to-Treat cancers